Similar Papers

Paper Title
Journal
Date
Author
Effect of tumor necrosis factor inhibitor treatment on proximal right coronary chronic total occlusion in a patient with rheumatoid arthritis.
Michael Behnes ... Hans Neuser
Circulation | VOL. 131
Michael Behnes, et. al.Michael Behnes ... Hans Neuser
26 Jan 2015
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality
...
Ophthalmology | VOL. 130
, et. al. ...
26 Jul 2023
Adalimumab for the Treatment of Refractory Acne Conglobata
Freja Lærke Sand ... Simon Francis Thomsen
JAMA Dermatology | VOL. 149
Freja Lærke Sand, et. al.Freja Lærke Sand ... Simon Francis Thomsen
01 Nov 2013
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
Duncan Porter ... Iain B Mcinnes
The Lancet | VOL. 388
Duncan Porter, et. al.Duncan Porter ... Iain B Mcinnes
17 May 2016
View more papers

More From: Rheumatology Science and Practice

Paper Title
Journal
Date
Author
Clinical and instrumental characteristics of psoriatic arthritis in men depending on testosterone levels
T S Panevin ... R V Rozhivanov
Rheumatology Science and Practice | VOL. 62
T S Panevin, et. al.T S Panevin ... R V Rozhivanov
27 Dec 2024
Enchondromatosis (Ollier’s disease): literature review and clinical case description
L N Denisov ... V A Nesterenko
Rheumatology Science and Practice | VOL. 62
L N Denisov, et. al.L N Denisov ... V A Nesterenko
27 Dec 2024
Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
A V Arshinov ... V I Emanuylov
Rheumatology Science and Practice | VOL. 62
A V Arshinov, et. al.A V Arshinov ... V I Emanuylov
27 Dec 2024
Factors of coxitis progression in patients with axial spondyloarthritis. Results of a two-year dynamic observation
E M Agafonova ... A V Smirnov
Rheumatology Science and Practice | VOL. 62
E M Agafonova, et. al.E M Agafonova ... A V Smirnov
27 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.